ABBOTT AMONG 2015 MOST INNOVATIVE COMPANIES

In 2015, Thomson Reuters named Abbott to its global ‘Top 100’ most innovative companies for third consecutive year.

Top 100 Global Innovators

Nov 12 2015

Abbott was recently recognized as one of the world's most innovative companies, securing a spot on the Thomson Reuters 2015 Top 100 Global Innovators list for the third consecutive year.

This prestigious list, established in 2011, recognizes companies around the world for their outstanding commitment to innovation, the protection of ideas and the commercialization of inventions.

New for 2015 was a closer look at the San Francisco Bay Area, where Abbott’s vascular and diabetes care businesses were recognized as top innovators.

Recent examples of Abbott innovation:

  • Abbott's FreeStyle® Libre Flash Glucose Monitoring System, a revolutionary new glucose sensing technology launched in Europe for people with diabetes
  • Abbott's TECNIS® Symfony Extended Range of Vision intraocular lens, a first-of-its-kind lens used in cataract treatment in Europe and other countries to provide clear vision at all distances.1
  • Abbott's MitraClip® System, a first-of-its-kind, catheter-based device that has transformed the treatment of certain kinds of mitral regurgitation (MR) for people who are too frail for open-heart surgery or those who are not candidates for surgery, recently honored with a Chicago Innovation Award. For important safety information please click here.
  • Abbott's AbsorbTM, a first-of-its-kind device that functions like a permanent, metallic stent by opening a blocked artery in the heart, restoring blood flow and providing relief from symptoms of coronary artery disease (CAD). However, unlike a metallic stent, which permanently restricts vessel movement and limits future treatment options, Absorb is made of a naturally dissolvable material that leaves behind an unrestricted vessel with restored vessel function with the potential to flex, pulse and dilate in response to various demands on the heart(2,3). Absorb is available in more than 100 countries and is an investigational product in the U.S.
  • Abbott's iDesign Advanced WaveScan StudioTM System, now available in the U.S. The iDesign System acts as the "brain" of the LASIK procedure, measuring and mapping irregularities of the eye that may impact vision.

The Top 100 Global Innovators list, an initiative of the IP Solutions business of Thomson Reuters, honors the 100 corporations and institutions around the world that are at the heart of innovation, as measured by a series of proprietary patent-related metrics. The full report and related methodology is available at http://www.top100innovators.com.

 

REFERENCES

1. The TECNIS Symfony IOL is not approved or available for sale in the United States. *CAUTION - Investigational Device. Limited by Federal (or United States) law to investigational use.
2. Absorb completely dissolves except for two pairs of tiny metallic markers, which help guide placement and remain in the artery to enable a physician to see where the device was placed.
3. Preliminary evidence suggests that natural vessel function is possible and preserves the vessel for future interventions.

true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?